1. Intravesical Oxybutynin for Urgent Bladder Rescue in a Newborn with Posterior Urethral Valves
- Author
-
Ana Lavilla Oiz, Concepción Goñi Orayen, Ada Yessenia Molina Caballero, Gemma Sierra Colomina, Yolanda Armendariz Cuevas, and Alberto Pérez Martínez
- Subjects
medicine.medical_specialty ,lcsh:Surgery ,Case Report ,Anticholinergic agents ,urologic and male genital diseases ,03 medical and health sciences ,Bladder outlet obstruction ,intravesical ,0302 clinical medicine ,030225 pediatrics ,medicine ,High doses ,Oxybutynin ,detrusor hypertrophy ,Ureterovesical junction obstruction ,business.industry ,lcsh:RJ1-570 ,Bladder catheterization ,lcsh:Pediatrics ,lcsh:RD1-811 ,posterior urethral valves ,oxybutynin ,Surgery ,Upper tract ,030211 gastroenterology & hepatology ,business ,Urethral valve ,medicine.drug - Abstract
Posterior urethral valves are the most common cause of bladder outlet obstruction in male newborns. Initial catheter drainage alleviates the urethral obstruction before definitive management by valve ablation. Newborns with posterior urethral valves often present with hypercontractile bladders that may inhibit upper tract drainage despite bladder catheterization. Anticholinergic agents are commonly used to treat detrusor hyperactivity, with oxybutynin being the most commonly used. We report the first case of a newborn with posterior urethral valves and ureterovesical junction obstruction caused by detrusor hypertrophy who underwent urgent intravesical instillation of oxybutynin at high doses in an attempt to avoid a diversion procedure.
- Published
- 2019